A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access Program
Clinical trial NCT07429942 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07429942
- Sponsor
- Takeda
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-08-31
- Primary completion
- 2026-10-30
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.